HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Clinical trials for HORMONE-RECEPTOR-POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE-RECEPTOR-POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HORMONE-RECEPTOR-POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug slow breast cancer growth?
Disease control Not yet recruitingThis phase 2 trial investigates whether tirzepatide, a drug used for weight loss and diabetes, can slow tumor growth in people with early-stage hormone-receptor-positive breast cancer. Participants receive tirzepatide alone, the standard hormone therapy letrozole alone, or both t…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Monthly vs. quarterly shots: can a simple switch boost ovarian suppression in young breast cancer?
Disease control Not yet recruitingThis Phase 2 trial will enroll 100 young women (ages 18-45) with hormone receptor-positive breast cancer who are already on a 3-month GnRH injection for ovarian suppression. Half will switch to a monthly injection, while the other half stays on the 3-month schedule. The study aim…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Blood test may guide breast cancer therapy, reducing chemo need
Disease control Not yet recruitingThis phase 2 trial tests a personalized approach for early-stage, hormone receptor-positive breast cancer. Participants receive a combination of CDK4/6 inhibitors and endocrine therapy before surgery. A blood test (ctDNA) is used to monitor tumor DNA and may help decide if chemot…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Ear zaps may soothe painful side effect of breast cancer drugs
Symptom relief Not yet recruitingThis study tests whether a gentle electrical stimulation on the ear (called taVNS) can reduce joint and muscle pain caused by aromatase inhibitors, a common breast cancer treatment. 216 women with hormone-positive breast cancer will receive either real or sham stimulation daily f…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can acupuncture cool hot flashes in breast cancer survivors?
Symptom relief Not yet recruitingThis study tests whether acupuncture can safely reduce hot flashes in women with hormone receptor-positive breast cancer who are on hormone therapy. Sixty patients will receive either real or sham acupuncture three times a week for eight weeks, then be followed for 16 more weeks.…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Can blood tests predict severe diarrhea from breast cancer drug?
Knowledge-focused Not yet recruitingThis study will enroll 235 women with hormone receptor-positive, HER2-negative breast cancer who are taking abemaciclib after surgery. Researchers want to see if higher levels of the drug in the blood are linked to severe diarrhea, a common side effect. By understanding this link…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: PHASE4 • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New tool could help breast cancer patients know their fertility future
Knowledge-focused Not yet recruitingThis observational study will follow 300 women aged 45-55 with hormone receptor-positive breast cancer to see if changes in a hormone called AMH can predict when they will reach menopause. Researchers will collect blood samples at seven time points and track menstrual patterns. T…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Sponsor: Shengjing Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New app aims to help breast cancer patients stick with Long-Term treatment
Knowledge-focused Not yet recruitingThis study is testing a new web and mobile app called SHIELD, designed to support women with hormone receptor-positive breast cancer who are on long-term hormone therapy. The goal is to see if the app is easy to use and helpful for managing treatment. About 30 women will particip…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC